Robert W. Baird Forecasts Strong Price Appreciation for Edwards Lifesciences (NYSE:EW) Stock
Edwards Lifesciences (NYSE:EW – Get Free Report) had its price objective lifted by analysts at Robert W. Baird from $72.00 to $75.00 in a note issued to investors on Thursday,Benzinga reports. The firm currently has a “neutral” rating on the medical research company’s stock. Robert W. Baird’s price target indicates a potential downside of 1.39% […]
Edwards Lifesciences (NYSE:EW – Get Free Report) had its price objective lifted by analysts at Robert W. Baird from $72.00 to $75.00 in a note issued to investors on Thursday,Benzinga reports. The firm currently has a “neutral” rating on the medical research company’s stock. Robert W. Baird’s price target indicates a potential downside of 1.39% […]
